Is 89bio, Inc. (ETNB) a Buy, Sell, or Hold?
NASDAQ : ETNB
89bio, Inc.
$14.84 USD
$0 (0.0%)
- Volume
- 38.51M
- Average Volume
- 5.39M
- Market Capitalization
- $2.2B
- P/E Ratio
- -12.37
- Dividend Yield
- 0.00%
- Price Target
- $14.50
- Year High
- $15.06
- Year Low
- $4.16
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $15.19
Insider Activity Summary (Last 12 Months)
Insiders Buying
31
Insiders Selling
109
Amount of Insider Selling
$8.87M
ETNB Insider Buying/Selling by Quarter
ETNB Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2025-10-30 | D-Return | 9.98 | 2025-11-03 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2025-10-30 | D-Return | 24.16 | 2025-11-03 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2025-10-30 | D-Return | 9.6 | 2025-11-03 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2025-10-30 | D-Return | 21.4 | 2025-11-03 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2025-10-30 | D-Return | 24.29 | 2025-11-03 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2025-10-30 | D-Return | 14.7 | 2025-11-03 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2025-10-30 | D-Return | 14.5 | 2025-11-03 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2025-10-30 | D-Return | 0.001 | 2025-11-03 |
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | 2025-10-30 | D-Return | 2.64 | 2025-11-03 |
| LAPORTE KATHLEEN | director | 2025-10-30 | D-Return | 9.98 | 2025-10-30 |
| LAPORTE KATHLEEN | director | 2025-10-30 | D-Return | 9.6 | 2025-10-30 |
| LAPORTE KATHLEEN | director | 2025-10-30 | D-Return | 14.7 | 2025-10-30 |
| LAPORTE KATHLEEN | director | 2025-10-30 | D-Return | 18.68 | 2025-10-30 |
| LAPORTE KATHLEEN | director | 2025-10-30 | D-Return | 2.64 | 2025-10-30 |
| Hayden Michael R | director | 2025-10-30 | U-Tender | 14.5 | 2025-10-30 |
| Hayden Michael R | director | 2025-10-30 | D-Return | 9.6 | 2025-10-30 |
| Hayden Michael R | director | 2025-10-30 | D-Return | 9.98 | 2025-10-30 |
| Hayden Michael R | director | 2025-10-30 | D-Return | 14.7 | 2025-10-30 |
| Hayden Michael R | director | 2025-10-30 | D-Return | 24.29 | 2025-10-30 |
| Hayden Michael R | director | 2025-10-30 | D-Return | 24.16 | 2025-10-30 |
| Hayden Michael R | director | 2025-10-30 | D-Return | 3.11 | 2025-10-30 |
| Hayden Michael R | director | 2025-10-30 | D-Return | 1.93 | 2025-10-30 |
| Hayden Michael R | director | 2025-10-30 | D-Return | 21.4 | 2025-10-30 |
| Hayden Michael R | director | 2025-10-30 | D-Return | 2.64 | 2025-10-30 |
| Martins Ryan | officer: Chief Financial Officer | 2025-10-30 | A-Award | 0 | 2025-10-30 |
| Martins Ryan | officer: Chief Financial Officer | 2025-10-30 | D-Return | 9.98 | 2025-10-30 |
| Martins Ryan | officer: Chief Financial Officer | 2025-10-30 | D-Return | 32.5 | 2025-10-30 |
| Martins Ryan | officer: Chief Financial Officer | 2025-10-30 | D-Return | 23.01 | 2025-10-30 |
| Martins Ryan | officer: Chief Financial Officer | 2025-10-30 | D-Return | 14.7 | 2025-10-30 |
| Martins Ryan | officer: Chief Financial Officer | 2025-10-30 | D-Return | 9.6 | 2025-10-30 |
| Martins Ryan | officer: Chief Financial Officer | 2025-10-30 | D-Return | 4.44 | 2025-10-30 |
| Martins Ryan | officer: Chief Financial Officer | 2025-10-30 | U-Tender | 14.5 | 2025-10-30 |
| Altschuler Steven | director | 2025-10-30 | D-Return | 23.22 | 2025-10-30 |
| Altschuler Steven | director | 2025-10-30 | D-Return | 24.16 | 2025-10-30 |
| Altschuler Steven | director | 2025-10-30 | D-Return | 24.29 | 2025-10-30 |
| Altschuler Steven | director | 2025-10-30 | D-Return | 2.64 | 2025-10-30 |
| Altschuler Steven | director | 2025-10-30 | D-Return | 9.6 | 2025-10-30 |
| Altschuler Steven | director | 2025-10-30 | D-Return | 14.7 | 2025-10-30 |
| Altschuler Steven | director | 2025-10-30 | D-Return | 9.98 | 2025-10-30 |
| PALEKAR ROHAN | director, officer: Chief Executive Officer | 2025-10-30 | A-Award | 0 | 2025-10-30 |
| PALEKAR ROHAN | director, officer: Chief Executive Officer | 2025-10-30 | D-Return | 14.7 | 2025-10-30 |
| PALEKAR ROHAN | director, officer: Chief Executive Officer | 2025-10-30 | D-Return | 4.44 | 2025-10-30 |
| PALEKAR ROHAN | director, officer: Chief Executive Officer | 2025-10-30 | D-Return | 3.11 | 2025-10-30 |
| PALEKAR ROHAN | director, officer: Chief Executive Officer | 2025-10-30 | D-Return | 32.5 | 2025-10-30 |
| PALEKAR ROHAN | director, officer: Chief Executive Officer | 2025-10-30 | D-Return | 23.01 | 2025-10-30 |
| PALEKAR ROHAN | director, officer: Chief Executive Officer | 2025-10-30 | D-Return | 9.6 | 2025-10-30 |
| PALEKAR ROHAN | director, officer: Chief Executive Officer | 2025-10-30 | D-Return | 9.98 | 2025-10-30 |
| PALEKAR ROHAN | director, officer: Chief Executive Officer | 2025-10-30 | U-Tender | 14.5 | 2025-10-30 |
| PALEKAR ROHAN | director, officer: Chief Executive Officer | 2025-10-30 | D-Return | 1.93 | 2025-10-30 |
| McWherter Charles | director | 2025-10-30 | D-Return | 8.39 | 2025-10-30 |
| McWherter Charles | director | 2025-10-30 | D-Return | 9.6 | 2025-10-30 |
| McWherter Charles | director | 2025-10-30 | U-Tender | 14.5 | 2025-10-30 |
| Atkinson Edward Morrow III | director | 2025-10-30 | D-Return | 9.98 | 2025-10-30 |
| Atkinson Edward Morrow III | director | 2025-10-30 | D-Return | 9.6 | 2025-10-30 |
| Atkinson Edward Morrow III | director | 2025-10-30 | D-Return | 4.44 | 2025-10-30 |
| Atkinson Edward Morrow III | director | 2025-10-30 | D-Return | 14.7 | 2025-10-30 |
| Zoth Lota S. | director | 2025-10-30 | D-Return | 24.05 | 2025-10-30 |
| Zoth Lota S. | director | 2025-10-30 | D-Return | 9.98 | 2025-10-30 |
| Zoth Lota S. | director | 2025-10-30 | D-Return | 24.16 | 2025-10-30 |
| Zoth Lota S. | director | 2025-10-30 | D-Return | 14.7 | 2025-10-30 |
| Zoth Lota S. | director | 2025-10-30 | D-Return | 2.64 | 2025-10-30 |
| Zoth Lota S. | director | 2025-10-30 | D-Return | 9.6 | 2025-10-30 |
| Le-Nguyen Quoc | officer: See Remarks | 2025-10-30 | A-Award | 0 | 2025-10-30 |
| Le-Nguyen Quoc | officer: See Remarks | 2025-10-30 | D-Return | 10.58 | 2025-10-30 |
| Le-Nguyen Quoc | officer: See Remarks | 2025-10-30 | D-Return | 23.01 | 2025-10-30 |
| Le-Nguyen Quoc | officer: See Remarks | 2025-10-30 | D-Return | 3.11 | 2025-10-30 |
| Le-Nguyen Quoc | officer: See Remarks | 2025-10-30 | D-Return | 4.44 | 2025-10-30 |
| Le-Nguyen Quoc | officer: See Remarks | 2025-10-30 | U-Tender | 14.5 | 2025-10-30 |
| Le-Nguyen Quoc | officer: See Remarks | 2025-10-30 | D-Return | 14.7 | 2025-10-30 |
| Le-Nguyen Quoc | officer: See Remarks | 2025-10-30 | D-Return | 9.98 | 2025-10-30 |
| Le-Nguyen Quoc | officer: See Remarks | 2025-10-30 | D-Return | 9.6 | 2025-10-30 |
| Le-Nguyen Quoc | officer: See Remarks | 2025-10-30 | D-Return | 32.5 | 2025-10-30 |
| Babler Martin | director | 2025-10-30 | D-Return | 8.86 | 2025-10-30 |
| Babler Martin | director | 2025-10-30 | D-Return | 9.6 | 2025-10-30 |
| DiRocco Derek | director | 2025-10-30 | D-Return | 24.29 | 2025-10-30 |
| DiRocco Derek | director | 2025-10-30 | D-Return | 9.98 | 2025-10-30 |
| DiRocco Derek | director | 2025-10-30 | D-Return | 21.4 | 2025-10-30 |
| DiRocco Derek | director | 2025-10-30 | D-Return | 2.64 | 2025-10-30 |
| DiRocco Derek | director | 2025-10-30 | D-Return | 14.7 | 2025-10-30 |
| DiRocco Derek | director | 2025-10-30 | D-Return | 9.6 | 2025-10-30 |
| DiRocco Derek | director | 2025-10-30 | D-Return | 24.16 | 2025-10-30 |
| Sarena Francis Willard | officer: Chief Operating Officer | 2025-10-30 | D-Return | 8.39 | 2025-10-30 |
| Sarena Francis Willard | officer: Chief Operating Officer | 2025-10-30 | D-Return | 9.6 | 2025-10-30 |
| Sarena Francis Willard | officer: Chief Operating Officer | 2025-10-30 | U-Tender | 14.5 | 2025-10-30 |
| Mansbach Harry H | officer: Chief Medical Officer | 2025-10-30 | A-Award | 0 | 2025-10-30 |
| Mansbach Harry H | officer: Chief Medical Officer | 2025-10-30 | D-Return | 9.6 | 2025-10-30 |
| Mansbach Harry H | officer: Chief Medical Officer | 2025-10-30 | D-Return | 14.7 | 2025-10-30 |
| Mansbach Harry H | officer: Chief Medical Officer | 2025-10-30 | D-Return | 32.5 | 2025-10-30 |
| Mansbach Harry H | officer: Chief Medical Officer | 2025-10-30 | D-Return | 4.44 | 2025-10-30 |
| Mansbach Harry H | officer: Chief Medical Officer | 2025-10-30 | D-Return | 3.11 | 2025-10-30 |
| Mansbach Harry H | officer: Chief Medical Officer | 2025-10-30 | D-Return | 1.93 | 2025-10-30 |
| Mansbach Harry H | officer: Chief Medical Officer | 2025-10-30 | D-Return | 23.01 | 2025-10-30 |
| Mansbach Harry H | officer: Chief Medical Officer | 2025-10-30 | U-Tender | 14.5 | 2025-10-30 |
| Mansbach Harry H | officer: Chief Medical Officer | 2025-10-30 | D-Return | 9.98 | 2025-10-30 |
| Martins Ryan | officer: Chief Financial Officer | 2025-10-22 | M-Exempt | 4.44 | 2025-10-23 |
| Martins Ryan | officer: Chief Financial Officer | 2025-10-22 | M-Exempt | 3.11 | 2025-10-23 |
| Martins Ryan | officer: Chief Financial Officer | 2025-10-22 | M-Exempt | 4.44 | 2025-10-23 |
| Martins Ryan | officer: Chief Financial Officer | 2025-10-22 | M-Exempt | 3.11 | 2025-10-23 |
| Le-Nguyen Quoc | officer: See Remarks | 2025-08-01 | F-InKind | 9.16 | 2025-08-05 |
| Le-Nguyen Quoc | officer: See Remarks | 2025-08-01 | F-InKind | 9.16 | 2025-08-05 |